Plerixafor Injection
FDA Label NDC 70771-1776

The following Structured Product Label (SPL) was submitted to the FDA by Zydus Lifesciences Limited for the product Plerixafor (NDC 70771-1776). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.

This specific version of the label includes detailed information regarding package label.principal display panel, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.

Package Label.Principal Display Panel

NDC 70771-1776-1

Plerixafor Injection – 1.2 mL vial label

24 mg/1.2 mL

(20 mg/mL)

For subcutaneous injection only

For single-dose only

Rx only

Vial Label (41b76e97 B780 4fc8 B073 13bf155ad8a5 01)

NDC 70771-1776-1

Carton contains one vial of

Plerixafor Injection

24 mg/1.2 mL

(20 mg/mL)

For subcutaneous injection only

See package insert for dosage and administration

For single-dose only

Rx only

Carton Label (41b76e97 B780 4fc8 B073 13bf155ad8a5 02)

* Please review the disclaimer below.